It was not until 2017 that Chik reported a case of pediatric PCP initially diagnosed histopathologically without BRAF V600E testing, but upon recurrence in adulthood, the mutation was detected, and the patient responded well to BRAF inhibitor therapy [60]. Here, BRAF is linked to pneumocystosis.